Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E C A B Willemsen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Clinical Pharmacology|February 9, 2023
Dihydropyrimidine dehydrogenase phenotype in peripheral blood mononuclear cells is related to adverse events of fluoropyrimidine-therapyK R Doornhof, P D van der Linden, G M Boeke, et al.
European Journal of Clinical Pharmacology|December 10, 2017
Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancerA E C A B Willemsen, L M Knapen, Y M de Beer, et al.
Pathology, Research and Practice|August 29, 2020
STAT3 as a predictive biomarker in head and neck cancer: A validation studyN J van Ruitenbeek, L L van der Woude, J H van Krieken, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Pharmacology|February 9, 2023
Dihydropyrimidine dehydrogenase phenotype in peripheral blood mononuclear cells is related to adverse events of fluoropyrimidine-therapyK R Doornhof, P D van der Linden, G M Boeke, et al.
European Journal of Clinical Pharmacology|December 10, 2017
Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancerA E C A B Willemsen, L M Knapen, Y M de Beer, et al.
Pathology, Research and Practice|August 29, 2020
STAT3 as a predictive biomarker in head and neck cancer: A validation studyN J van Ruitenbeek, L L van der Woude, J H van Krieken, et al.
Pageof 1